Source: Pharmaceutical Benefits Scheme (AU) Revision Year: 2019 Publisher: Alphapharm Pty Ltd, Level 1, 30 The Bond, 30-34 Hickson Road, Millers Point NSW 2000, www.mylan.com.au
Severe cases of insomnia.
In most patients, Hypnodorm need only be administered for a few nights. Treatment should be discontinued gradually by decreasing the dosage.
Dosage should be selected carefully, due consideration being given to the patient’s age and general condition, as well as the type of sleep disturbance.
The drug should be taken immediately before going to bed. In general, the following dosages are recommended.
1 to 2 mg on going to bed.
0.5 to 1 mg.
Elimination of metabolites will be impaired. For these patients, commence treatment with small doses which are increased slowly until the desired response is attained.
Overdosage of benzodiazepines is usually manifested by degrees of central nervous system depression, ranging from drowsiness to coma. In mild cases, symptoms include drowsiness, mental confusion and lethargy. In more serious cases, symptoms may include ataxia, hypotonia, hypotension, respiratory depression, coma, and very rarely death.
In the management of overdosage with any medication, it should be borne in mind that multiple agents may have been taken.
Following overdosage with flunitrazepam tablets, activated charcoal should be given to reduce absorption. General symptomatic and supportive measures are recommended. Hypotension and respiratory depression should be managed according to general principles.
Haemoperfusion and haemodialysis are not useful in benzodiazepine intoxication. The benzodiazepine antagonist flumazenil may be used in hospitalised patients for the reversal of acute benzodiazepine effects. Please consult the flumazenil product information prior to usage.
If excitation occurs in patients following overdosage, barbiturates should not be used.
For information on the management of overdose, contact the Poisons Information Centre on 13 11 26 (Australia).
Shelf life: In Australia, information on the shelf life can be found on the public summary of the Australian Register of Therapeutic Goods (ARTG). The expiry date can be found on the packaging.
Store below 30°C.
Available in HDPE bottles of 30 tablets.
In Australia, any unused medicine or waste material should be disposed of by taking it to your local pharmacy.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
